mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.6 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.6 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |